Gritstone bio to Participate in Upcoming Investor and Scientific Conferences
Gritstone bio, a clinical-stage biotechnology company, announced its participation in several upcoming investor and scientific conferences. The events include:
1. Goldman Sachs 45th Annual Global Healthcare Conference on June 11, 2024, in Miami, FL.
2. JonesHealthcare Seaside Summit 2024 from July 15-16 in Encinitas, CA.
3. 4th Annual mRNA-Based Therapeutics Summit on July 30, 2024, in Boston, MA.
Some events will be webcasted live, with details available on Gritstone bio’s website.
- Participation in major conferences can increase Gritstone bio's visibility and attractiveness to investors.
- Involvement in the Goldman Sachs conference provides networking opportunities with key stakeholders in the healthcare sector.
- Active engagement in the mRNA-Based Therapeutics Summit highlights Gritstone bio's commitment to advancing mRNA technology.
- No direct financial or clinical data updates were provided in the announcement.
- High participation costs in such conferences could strain financial resources.
EMERYVILLE, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced that management will be participating in the following investor and scientific conferences:
Goldman Sachs 45th Annual Global Healthcare Conference (Fireside Chat*)
Date and Time: Tuesday, June 11, 2024 at 1:20pm ET
Location: Miami, FL
JonesHealthcare Seaside Summit 2024 (1x1s)
Dates: Monday, July 15 - Tuesday, July 16
Location: Encinitas, CA
4th Annual mRNA-Based Therapeutics Summit (Panel)
Panel Title: Unpacking 2024’s Successes & Anticipating the Next Challenges to Advance the Future of mRNA-Based Therapeutics & Vaccines
Date and Time: Tuesday, July 30, 2024 at 8:30am ET
Location: Boston, MA
Select events (marked by *) will be webcasted live and webcast details will be available on the ‘Events’ page of Gritstone bio’s website: https://ir.gritstonebio.com/investors/events. Archived replays will be accessible for 30 days following each event.
About Gritstone bio
Gritstone bio, Inc. (Nasdaq: GRTS) is a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines. We leverage our innovative vectors and payloads to train multiple arms of the immune system to attack critical disease targets. Independently and with our collaborators, we are advancing a portfolio of product candidates to treat and prevent viral diseases and solid tumors in pursuit of improving patient outcomes and eliminating disease. www.gritstonebio.com
Gritstone Contacts
Investors:
George E. MacDougall
Gritstone bio, Inc.
ir@gritstone.com
Media:
Dan Budwick
1AB
(973) 271-6085
dan@1abmedia.com
FAQ
When will Gritstone bio participate in the Goldman Sachs 45th Annual Global Healthcare Conference?
Where is the JonesHealthcare Seaside Summit 2024?
What event will Gritstone bio attend on July 30, 2024?
Which Gritstone bio events will be webcasted?
